BASEL MED GROUP LTD. O.N.

The Basel Medical Group has appointed Neo Chun How Alton as interim CFO with effect from Monday. He succeeds Jianing Lu, who resigned as chief financial officer. Neo brings experience in corporate finance, restructuring, forensic accounting and tax policy, and was most recently deputy CEO of InCorp Global and worked as a part-time lecturer. » More on de.investing.com

Basel Medical Group reports that the noncompliance with periodic reporting obligations was cured after filing the amended annual report on Form 20-F with the SEC on March 13, 2026, and that it meets NASDAQ rule 5250(c)(1). The stock rose nearly 16% last week to $0.69 but is down 83% year-to-date. The company reports more cash than debt, has a market capitalization of $12.96 million and operates clinical sites in Singapore. » More on de.investing.com